{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T14:43:00Z","timestamp":1783521780722,"version":"3.55.0"},"reference-count":56,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T00:00:00Z","timestamp":1673568000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004735","name":"Natural Science Foundation of\u00a0Hunan Province","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004735","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018904","name":"Beijing Xisike Clinical Oncology Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018904","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Cell. Infect. Microbiol."],"abstract":"<jats:sec><jats:title>Introduction<\/jats:title><jats:p>Carbapenem resistant gram-negative bacteria (CRGNB) infection is more and more frequent in patients after hematopoietic stem cell transplantation (HSCT), and the prognosis is very poor. The purpose of this study was to investigate the clinical characteristics and risk factors for mortality with CRGNB infection in HSCT recipients, and to provide useful information for guiding the application of antibiotics and improving the prognosis in the future.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods<\/jats:title><jats:p>Electronic medical records of CRGNB infected patients who underwent HSCT in Xiangya Hospital from January 1, 2015 to June 30, 2022 were collected. At the same time, 1:1 case-control matching was performed according to gender, age and disease type. The epidemiological characteristics and drug resistance of patients with CRGNB infection and non-CRGNB infection were compared. Logistic regression and Cox regression analysis were used to determine the risk factors for CRGNB acquisition and death respectively, and a prediction model of overall survival was constructed by R language.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results and Discussion<\/jats:title><jats:p>The crude infection rate of CRGNB in HSCT recipients was 7.42%, and the mortality rate was 47.1%. CRGNB was resistant to most commonly used antibiotics. Time interval from diagnosis to transplantation &amp;gt;180 days (HR=7.886, 95% CI 2.624-23.703, <jats:italic>P<\/jats:italic>=0.000), septic shock (HR=6.182, 95% CI 2.605-14.671, <jats:italic>P<\/jats:italic>=0.000), platelet count &amp;lt; 20 \u00d7 10<jats:sup>9<\/jats:sup>\/L (HR=2.615, 95% CI 1.152-5.934, <jats:italic>P<\/jats:italic>=0.022) and total bilirubin &amp;gt; 34.2 \u03bcmol\/L (HR=7.348, 95% CI 2.966-18.202, <jats:italic>P<\/jats:italic>=0.000) at the initial stage of infection were 4 independent risk factors associated with mortality. CRGNB infection has become a serious threat to HSCT recipients. Clinicians should pay high attention to it and actively seek personalized treatment strategies suitable for local medical conditions.<\/jats:p><\/jats:sec>","DOI":"10.3389\/fcimb.2022.1098856","type":"journal-article","created":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T04:46:03Z","timestamp":1673585163000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":4,"title":["Epidemiology, antimicrobial resistance, and mortality risk factors of carbapenem resistant gram-negative bacteria in hematopoietic stem cell transplantation recipients"],"prefix":"10.3389","volume":"12","author":[{"given":"Yan","family":"Jia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziyue","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuefeng","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2023,1,13]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"1228","DOI":"10.1002\/phar.2476","article-title":"Cefiderocol: a novel siderophore cephalosporin against multidrug-resistant gram-negative pathogens","volume":"40","author":"Abdul-Mutakabbir","year":"2020","journal-title":"Pharmacotherapy."},{"key":"B2","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/j.trre.2017.07.001","article-title":"Management of multidrug resistant gram-negative bacilli infections in solid organ transplant recipients: SET\/GESITRA-SEIMC\/REIPI recommendations","volume":"32","author":"Aguado","year":"2018","journal-title":"Transplant. Rev. (Orlando)."},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofab371","article-title":"Real-world, multicenter experience with meropenem-vaborbactam for gram-negative bacterial infections including carbapenem-resistant enterobacterales and pseudomonas aeruginosa","volume":"8","author":"Alosaimy","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"B4","doi-asserted-by":"publisher","first-page":"1819","DOI":"10.1093\/cid\/cix646","article-title":"Antimicrobial resistance in gram-negative rods causing bacteremia in hematopoietic stem cell transplant recipients: Intercontinental prospective study of the infectious diseases working party of the European bone marrow transplantation group","volume":"65","author":"Averbuch","year":"2017","journal-title":"Clin. Infect. Dis."},{"key":"B5","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1016\/j.ijid.2021.03.004","article-title":"Treatment outcome and adverse effects of colistin in adult patients with carbapenem-resistant gram-negative bacteremia from Pakistan","volume":"106","author":"Babar","year":"2021","journal-title":"Int. J. Infect. Dis."},{"key":"B6","doi-asserted-by":"publisher","first-page":"e4521","DOI":"10.1093\/cid\/ciaa1464","article-title":"Changing epidemiology and decreased mortality associated with carbapenem-resistant gram-negative bacteri-2017","volume":"73","author":"Babiker","year":"2021","journal-title":"Clin. Infect. Dis."},{"key":"B7","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1016\/j.bbmt.2017.07.021","article-title":"Consensus report by pediatric acute lung injury and sepsis investigators and pediatric blood and marrow transplantation consortium joint working committees: supportive care guidelines for management of veno-occlusive disease in children and adolescents, part 1: Focus on investigations, prophylaxis, and specific treatment","volume":"23","author":"Bajwa","year":"2017","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1016\/j.soncn.2019.150950","article-title":"Acute leukemia: Diagnosis and treatment","volume":"35","author":"Blackburn","year":"2019","journal-title":"Semin. Oncol. Nurs."},{"key":"B9","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1111\/tid.12175","article-title":"Incidence, risk factors, and outcome of bloodstream infections during the pre-engraftment phase in 521 allogeneic hematopoietic stem cell transplantations","volume":"16","author":"Blennow","year":"2014","journal-title":"Transpl Infect. Dis."},{"key":"B10","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1016\/j.ijantimicag.2015.02.003","article-title":"Susceptibility of anaerobes to fusidic acid and fosfomycin","volume":"45","author":"Boyanova","year":"2015","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B11","first-page":"176e195","article-title":"Early complications after HSCT. ebmt-esh handbook on haematopoietic stem cell transplantation","author":"Carreras","year":"2012"},{"key":"B12","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1016\/j.ijantimicag.2018.07.027","article-title":"Loss of activity of ceftazidime-avibactam due to MexAB-OprM efflux and overproduction of AmpC cephalosporinase in pseudomonas aeruginosa isolated from patients suffering from cystic fibrosis","volume":"52","author":"Chalhoub","year":"2018","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13199","article-title":"Effectiveness of tigecycline in the treatment of infections caused by carbapenem-resistant gram-negative bacteria in pediatric liver transplant recipients: A retrospective study","volume":"22","author":"Chen","year":"2020","journal-title":"Transpl Infect. Dis."},{"key":"B14","doi-asserted-by":"publisher","first-page":"5603","DOI":"10.2147\/IDR.S342163","article-title":"Ceftazidime-avibactam as salvage treatment for infections due to carbapenem-resistant klebsiella pneumoniae in liver transplantation recipients","volume":"14","author":"Chen","year":"2021","journal-title":"Infect. Drug Resist."},{"key":"B15","doi-asserted-by":"publisher","first-page":"89","DOI":"10.3760\/cma.j.issn.0253-2727.2019.02.001","article-title":"Chinese Guidelines for diagnosis and treatment of myelodysplastic syndrome)","volume":"40","year":"2019","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B16","doi-asserted-by":"publisher","first-page":"969","DOI":"10.3760\/cma.j.issn.0253-2727.2020.12.001","article-title":"Chinese Guidelines for the clinical application of antibacterial drugs for agranulocytosis with feve)","volume":"41","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.ijantimicag.2021.106335","article-title":"The place of ceftazidime\/avibactam and ceftolozane\/tazobactam for therapy of haematological patients with febrile neutropenia","volume":"57","author":"Clerici","year":"2021","journal-title":"Int. J. Antimicrob. Agents."},{"key":"B18","doi-asserted-by":"publisher","first-page":"1271","DOI":"10.1016\/j.bbmt.2019.02.018","article-title":"Risk factors for development of and progression of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome","volume":"25","author":"Corbacioglu","year":"2019","journal-title":"Biol. Blood Marrow Transplant."},{"key":"B19","doi-asserted-by":"publisher","first-page":"444","DOI":"10.1111\/bjh.12558","article-title":"BCSH\/BSBMT guideline: Diagnosis and management of veno-occlusive disease (sinusoidal obstruction syndrome) following haematopoietic stem cell transplantation","volume":"163","author":"Dignan","year":"2013","journal-title":"Br. J. Haematol."},{"key":"B20","doi-asserted-by":"publisher","first-page":"807","DOI":"10.3760\/cma.j.issn.0253-2727.2021.10.003","article-title":"Analysing pathogenic bacterial spectrum and drug resistance of bloodstream infection in patients with allogeneic hematopoietic stem cell transplantation","volume":"42","author":"Ding","year":"2021","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B21","doi-asserted-by":"publisher","first-page":"S565","DOI":"10.1093\/cid\/ciz830","article-title":"Treatment options for carbapenem-resistant gram-negative bacterial infections","volume":"69","author":"Doi","year":"2019","journal-title":"Clin. Infect. Dis."},{"key":"B22","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1080\/22221751.2020.1754133","article-title":"Colistin and its role in the era of antibiotic resistance: An extended revie-2019)","volume":"9","author":"El-Sayed Ahmed","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"B23","doi-asserted-by":"publisher","first-page":"705","DOI":"10.3760\/cma.j.issn.0253-2727.2021.09.001","article-title":"Chinese Guidelines for diagnosis and treatment of adult acute lymphoblastic leukemi)","volume":"42","year":"2021","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B24","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1007\/s40265-021-01471-8","article-title":"Imipenem\/Cilastatin\/Relebactam: A review in gram-negative bacterial infections","volume":"81","author":"Heo","year":"2021","journal-title":"Drugs."},{"key":"B25","doi-asserted-by":"publisher","first-page":"755","DOI":"10.6004\/jnccn.2020.0026","article-title":"Hodgkin Lymphoma, version 2.2020, NCCN clinical practice guidelines in oncology","volume":"18","author":"Hoppe","year":"2020","journal-title":"J. Natl. Compr. Canc Netw."},{"key":"B26","doi-asserted-by":"publisher","first-page":"309","DOI":"10.1016\/j.ajic.2008.03.002","article-title":"CDC\/NHSN surveillance definition of health care-associated infection and criteria for specific types of infections in the acute care setting","volume":"36","author":"Horan","year":"2018","journal-title":"Am. J. Infect. Control."},{"key":"B27","doi-asserted-by":"publisher","first-page":"958","DOI":"10.3760\/cma.j.issn.0253-2727.2020.11.018","article-title":"Advance in hematopoietic and immune reconstitution of allogeneic stem cell transplantation","volume":"41","author":"Huo","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B28","volume-title":"Hematopoietic stem cell transplantation","author":"Khaddour","year":"2022"},{"key":"B29","doi-asserted-by":"publisher","first-page":"617","DOI":"10.3760\/cma.j.issn.0253-2727.2021.08.001","article-title":"Chinese Guidelines for the diagnosis and treatment of adult acute myeloid leukemia (not APL) (2021)","volume":"42","year":"2021","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B30","doi-asserted-by":"publisher","first-page":"5011","DOI":"10.2147\/IDR.S376763","article-title":"Epidemiology, drug resistance, and risk factors for mortality among hematopoietic stem cell transplantation recipients with hospital-acquired klebsiella pneumoniae infections: A single-center retrospective study from China","volume":"15","author":"Liu","year":"2022","journal-title":"Infect. Drug Resist."},{"key":"B31","doi-asserted-by":"publisher","first-page":"e00779","DOI":"10.1128\/AAC.00779-19","article-title":"Evaluation of the synergy of ceftazidime-avibactam in combination with meropenem, amikacin, aztreonam, colistin, or fosfomycin against well-characterized multidrug-resistant klebsiella pneumoniae and pseudomonas aeruginosa","volume":"63","author":"Mikhail","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"B32","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1007\/s15010-011-0229-y","article-title":"Mortality after bloodstream infections in allogeneic haematopoietic stem cell transplant (HSCT) recipients","volume":"40","author":"Mikulska","year":"2012","journal-title":"Infection."},{"key":"B33","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1016\/j.jinf.2013.12.006","article-title":"Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients","volume":"68","author":"Mikulska","year":"2014","journal-title":"J. Infect."},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.3390\/eca2022-12691","article-title":"In vitro activity of ceftazidime-avibactam against ESBL producing and carbapenem-resistant gram\u2013negative bacteria recovered from blood and fecal samples of patients after hematopoietic stem-cell transplantation","author":"Niyazi","year":"2022","journal-title":"Sciforum"},{"key":"B35","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1016\/j.hemonc.2017.05.018","article-title":"Complications of hematopoietic stem cell transplantation: Bacterial infections","volume":"10","author":"Omrani","year":"2017","journal-title":"Hematol. Oncol. Stem Cell Ther."},{"key":"B36","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00277-004-0909-0","article-title":"Bacterial and fungal bloodstream isolates from 796 hematopoietic stem cell transplant recipients between 1991 and 2000","volume":"84","author":"Ortega","year":"2005","journal-title":"Ann. Hematol."},{"key":"B37","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1093\/cid\/ciz816","article-title":"Ceftolozane\/Tazobactam vs polymyxin or aminoglycoside-based regimens for the treatment of drug-resistant pseudomonas aeruginosa","volume":"71","author":"Pogue","year":"2020","journal-title":"Clin. Infect. Dis."},{"key":"B38","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1038\/sj.bmt.1705690","article-title":"Blood stream infection after hematopoietic stem cell transplantation is associated with increased mortality","volume":"40","author":"Poutsiaka","year":"2007","journal-title":"Bone Marrow Transplant."},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3390\/ph15040463","article-title":"Microbiological, clinical, and PK\/PD features of the new anti-gram-negative antibiotics: Beta-lactam\/beta-lactamase inhibitors in combination and cefiderocol-an all-inclusive guide for clinicians","volume":"15","author":"Principe","year":"2022","journal-title":"Pharm. (Basel)."},{"key":"B40","doi-asserted-by":"publisher","first-page":"171","DOI":"10.1186\/s12879-017-2276-1","article-title":"Factors influencing mortality in abdominal solid organ transplant recipients with multidrug-resistant gram-negative bacteremia","volume":"17","author":"Qiao","year":"2017","journal-title":"BMC Infect. Dis."},{"key":"B41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3760\/cma.j.issn.0253-2727.2017.01.001","article-title":"Chinese Expert consensus on the diagnosis and treatment of aplastic anemi)","volume":"38","year":"2017","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211053480","article-title":"Prevention and management of carbapenem-resistant enterobacteriaceae in haematopoietic cell transplantation","volume":"8","author":"Sahitya","year":"2021","journal-title":"Ther. Adv. Infect. Dis."},{"key":"B43","doi-asserted-by":"publisher","first-page":"961","DOI":"10.2217\/fmb.10.47","article-title":"Antimicrobial susceptibility of gram-negative nonurinary bacteria to fosfomycin and other antimicrobials","volume":"5","author":"Samonis","year":"2010","journal-title":"Future Microbiol."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e01379","DOI":"10.1128\/AAC.01379-18","article-title":"Mutation-driven evolution of pseudomonas aeruginosa in the presence of either ceftazidime or ceftazidime\/avibactam","volume":"62","author":"Sanz-Garc\u00eda","year":"2018","journal-title":"Antimicrob. Agents Chemother."},{"key":"B45","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.jinf.2016.07.002","article-title":"Bacteremia due to carbapenem-resistant enterobacteriaceae in neutropenic patients with hematologic malignancies","volume":"73","author":"Satlin","year":"2016","journal-title":"J. Infect."},{"key":"B46","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1093\/cid\/ciu052","article-title":"The global challenge of carbapenem-resistant enterobacteriaceae in transplant recipients and patients with hematologic malignancies","volume":"58","author":"Satlin","year":"2014","journal-title":"Clin. Infect. Dis."},{"key":"B47","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1093\/cid\/ciw113","article-title":"Causative organisms and associated antimicrobial resistance in healthcare-associated, central line-associated bloodstream infections from oncology setting-2012","volume":"62","author":"See","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B48","doi-asserted-by":"publisher","first-page":"1615","DOI":"10.1093\/cid\/ciw636","article-title":"Clinical outcomes, drug toxicity, and emergence of ceftazidime-avibactam resistance among patients treated for carbapenem-resistant enterobacteriaceae infections","volume":"63","author":"Shields","year":"2016","journal-title":"Clin. Infect. Dis."},{"key":"B49","doi-asserted-by":"publisher","first-page":"529","DOI":"10.3760\/cma.j.issn.0253-2727.2020.07.001","article-title":"Chinese Consensus of allogeneic hematopoietic stem cell transplantation for hematological disease (III) -acute graft-versus-host diseas)","volume":"41","year":"2020","journal-title":"Zhonghua Xue Ye Xue Za Zhi."},{"key":"B50","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1186\/s40001-021-00508-8","article-title":"Tandem fecal microbiota transplantation cycles in an allogeneic hematopoietic stem cell transplant recipient targeting carbapenem-resistant enterobacteriaceae colonization: A case report and literature review","volume":"26","author":"Su","year":"2021","journal-title":"Eur. J. Med. Res."},{"key":"B51","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1016\/j.cmi.2014.11.022","article-title":"Current epidemiology and antimicrobial resistance data for bacterial bloodstream infections in patients with hematologic malignancies: An Italian multicentre prospective survey","volume":"21","author":"Trecarichi","year":"2015","journal-title":"Clin. Microbiol. Infect."},{"key":"B52","doi-asserted-by":"publisher","first-page":"e493","DOI":"10.1097\/MPH.0000000000001556","article-title":"Gram-negative bacteremia in children with hematologic malignancies and following hematopoietic stem cell transplantation: Epidemiology, resistance, and outcome","volume":"41","author":"Vinker-Shuster","year":"2019","journal-title":"J. Pediatr. Hematol. Oncol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"3770","DOI":"10.12659\/msm.901884","article-title":"Confirmed transmission of bacterial or fungal infection to kidney transplant recipients from donated after cardiac death (DCD) donors in China: A single-center analysis","volume":"23","author":"Wan","year":"2017","journal-title":"Med. Sci. Monit."},{"key":"B54","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1007\/s40121-021-00411-z","article-title":"Epidemiology, susceptibility, and risk factors associated with mortality in carbapenem-resistant gram-negative bacterial infections among abdominal solid organ transplant recipients: A retrospective cohort study","volume":"10","author":"Wu","year":"2021","journal-title":"Infect. Dis. Ther."},{"key":"B55","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00115-20","article-title":"New beta-lactam-beta-lactamase inhibitor combinations","volume":"34","author":"Yahav","year":"2020","journal-title":"Clin. Microbiol. Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"1603","DOI":"10.1038\/s41409-021-01215-y","article-title":"Incidence and risk factors of hepatic veno-occlusive disease\/sinusoidal obstruction syndrome after allogeneic hematopoietic cell transplantation in adults with prophylactic ursodiol and intravenous heparin or prostaglandin E1","volume":"56","author":"Yoon","year":"2021","journal-title":"Bone Marrow Transplant."}],"container-title":["Frontiers in Cellular and Infection Microbiology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1098856\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,13]],"date-time":"2023-01-13T04:46:10Z","timestamp":1673585170000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fcimb.2022.1098856\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,13]]},"references-count":56,"alternative-id":["10.3389\/fcimb.2022.1098856"],"URL":"https:\/\/doi.org\/10.3389\/fcimb.2022.1098856","relation":{},"ISSN":["2235-2988"],"issn-type":[{"value":"2235-2988","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,13]]},"article-number":"1098856"}}